Archives: Speakers

Dr. Ortega holds a doctorate in Molecular Biology and Analytical Chemistry from the University of Hawaii at Manoa. With a strong background in mass spectrometry, she serves as the Associate Director of Analytical Services at TriLink Biotechnologies. As part of the Analytical Development team, Dr. Ortega specializes in the physicochemical analysis of mRNA, oligonucleotides (i.e. gRNA), and small molecules such as NTPs and CleanCap® analogs. Her commitment to analytical excellence, combined with her scientific expertise, drives the development of robust methodologies to effectively fulfill client analytical requests and expand TriLink’s portfolio of analytical testing services.

Dr. Cody Palumbo is a Senior Application Scientist in Technical Design at TriLink BioTechnologies, where he partners with customers to support gRNA, oligonucleotide, and gene editing workflows by providing technical guidance and customized solutions. He brings deep expertise in CRISPR-based technologies and therapeutic development, drawing on years of experience across biotech and pharmaceutical settings. Prior to TriLink, Dr. Palumbo served as Associate Director of Gene Editing Process Development and Tech Transfer at Sana Biotechnology and led a team of Process Development scientists at Bristol Myers Squibb focused on gene editing tools for cell therapies. He holds a Ph.D. in Chemistry from the University of California, Davis. Dr. Palumbo is passionate about bridging technical innovation with real-world impact and frequently speaks on the evolving landscape of genome editing technologies.

Beatriz Valle trabaja en el equipo de Tecnología y Servicios Empresariales (ETS) de GlobalData. Su función consiste en el análisis competitivo de las tendencias tecnológicas en torno a los centros de datos y las tecnologías de inteligencia artificial, con especial atención a la IA generativa, sus productos y servicios. Valle ha sido analista del sector desde 2006, trabajando para varias empresas globales y cuenta con experiencia en consultoría. Ha sido citada en numerosas publicaciones financieras y comerciales, como Reuters, Forbes, Computing, The Register, DataCenterDynamics, DataCenter Knowledge, Network World, Futurism, Tech Monitor, Wired, etc.

NIKEN PRAWESTI has embarked on her journey in the hospitality industry 15 years ago. Skilled in negotiation, business planning, and leadership, she founded and led Liberta Hotel International (LHI), a hotel management company focused on lifestyle hospitality since 2020. Her expertise lies in leveraging data-driven insights to craft targeted and innovative business solutions. Since its establishment, LHI has managed hotels and F&B establishments around Indonesia, transforming hospitality industry into a more dynamic and technology-driven one. Niken has also been an active contributor to the World Bank since 2017, specializing in Women, Business, and the Law Practice group. In her free time, she enjoys reading and golf.

A fermentation expert, author & founder of L.A Brewery.  Louise worked in the creative industry for 10 years before discovering her love for fermentation.  She started her first kombucha business in her kitchen in 2013, published her first drinks fermentation book in 2016 and launched L.A Brewery in 2017.  Louise is currently the Creative Director for L.A Brewery, writing her second book and teaches fermentation classes in her spare time.

Emma Thackray is the co-founder of Hip Pop, one of the UK’s fastest-growing challenger soft drink brands. She launched the business in 2019 with a clear goal: to make better-for-you drinks that taste great, without sweeteners or artificial ingredients. Hip Pop uses real fruit, live cultures and functional ingredients to deliver bold flavour with real benefits.

Before founding Hip Pop, Emma led Dolly Parton’s Imagination Library in the UK, she now brings that same purpose-driven approach to disrupting the soft drinks space.

Hip Pop’s award-winning sodas and kombuchas are stocked in major retailers including Sainsbury’s, Morrisons M&S, and Co-op. Under Emma’s leadership, the brand has won multiple Great Taste Awards and been recognised for its rapid growth and innovation.

For Emma, it is not just about what goes into your drink. It is about choosing better, feeling better and enjoying every sip.

Todd holds an MBA from the University of Manitoba. His career in brand and innovation has included living in Toronto, Geneva, Singapore and Hong Kong working with research giants Nielsen and YouGov and more recently C&C Group on the producer side. Todd joined the Ai Palette- Globaldata team in early 2025

His client work has included engagements with Starbucks, Heineken, Pernod Ricard, Dannon, Lidl, Ferrero, Disney, HSBC and The British Olympic Association

Jamie is a 15x Guinness world record holder and the founder of ACTIPH Water, launching in 2017 as the first alkaline ionised water in UK and are now exporting to 30 countries worldwide and are the market leader of the alkaline water category in Europe. Currently the no.1 selling water in the natural channel, no.1 selling food & drink item in Holland & Barrett, no.1 selling water on Amazon and was on the Tesco Incubator programme in 2022. Partnering with some of the biggest fitness events in Europe such as Hyrox, Tough Mudder, Spartan, Cross Fit, Run Through and have partnered with Disney’s Marvel Studios for Thor Love and Thunder in 2022 and Deadpool & Wolverine in 2024. ACTIPH is a lifestyle brand encouraging and enabling consumers to live active lives through healthier hydration.

邓晓宇先生拥有17年全球多区域医药研究开发经验，曾在多个国际领先的临床研究组织担任重要职务，包括 Labcorp、Syneos、Chiltern 和 Covance，并帮助多个亚太区企业在欧洲和美国开展医药产品临床研发工作。在新冠疫情期间，他成功领导了 Covance 亚太区的首个新冠临床研究。作为希毅医学的创始人，他带领公司帮助 80 多项生物医药项目在海外顺利落地。
邓晓宇先生毕业于哈佛大学流行病与临床试验专业，同时他也是美国项目管理协会认证项目管理专家，注册药剂师。

Xiaoyu Deng, has over 17 years of experience in global clinical research and development. Mr. Deng is a recognized expert in planning and executing clinical trials across diverse global regions. He has held key positions at leading international CROs, including Labcorp, Syneos, Chiltern, and Covance. During the COVID-19 pandemic, Mr. Deng successfully led the first COVID-19 study in the APAC region for Covance, demonstrating his ability to lead high-stakes research under tight timelines.
As the founder of MDCE, Mr. Deng has guided the company to substantial success, generating over 20 billion RMB in profits for its clients and helping more than 80 Chinese medical devices and drug products successfully land overseas.
Mr. Deng holds a Master’s degree in Public Health (Epidemiology) from Harvard University’s T.H. Chan School of Public Health. He is also a certified Project Management Professional (PMP), and a licensed pharmacist.

With 16 years of deep expertise in the clinical operations industry, Vincent Zang has previously worked at ICON, Johnson & Johnson, and Simcere Pharmaceutical. In 2019, he joined Innovent Biologics, where he has been involved in the full lifecycle clinical development of multiple drugs (including small molecule chemicals, monoclonal antibodies, bispecific antibodies, peptides, etc.), with several products successfully approved for market launch. He has accumulated extensive experience in novel drug clinical development.

臧文升在临床运营行业已深耕16年。曾就职于于ICON、强生、先声药业，2019年加入信达生物。承担过多项药物（小分子化药、单抗、双抗、多肽等）的临床开发的全阶段的工作，并已有多个产品成功获批上市。在新药临床开发方面积累了丰富的经验。